Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the related topics 'Multiple myeloma' and 'MedlinePlus Genetics' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T07:52:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added and Revision: v3.4.0 has been removed from the page's documents section.
    Difference
    0.1%
    Check dated 2026-02-05T18:57:05.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Related topics were added to the page, including Multiple Myeloma and MedlinePlus Genetics. The page revision was updated from v3.3.3 to v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-15T03:05:05.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Removed the related topics 'Multiple myeloma' and 'MedlinePlus Genetics' from the page.
    Difference
    0.2%
    Check dated 2025-12-31T17:55:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A dedicated Locations section now includes Massachusetts; the older Massachusetts Locations header is removed. The HHS Vulnerability Disclosure link was removed, and the page revision changed from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T14:48:25.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added related topics 'Multiple myeloma' and 'MedlinePlus Genetics' to the study page to provide clearer disease context and improve discoverability.
    Difference
    0.2%
    Check dated 2025-12-17T10:18:40.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.